30-Day Mortality and Cardiopulmonary Complication Rates in Patients Undergoing Emergency Surgery with Perioperative SARS-CoV-2 Infection by Sood MD, Akshay et al.
Wayne State University 
Medical Student Research Symposium School of Medicine 
January 2021 
30-Day Mortality and Cardiopulmonary Complication Rates in 
Patients Undergoing Emergency Surgery with Perioperative SARS-
CoV-2 Infection 
Akshay Sood MD 
Henry Ford Health System 
Nicholas Corsi 
Wayne State University, fv9108@wayne.edu 
Mohit Butaney MD 
Mayo Clinic 
Jacob Keeley MS 
Henry Ford Health System 
Chandler Bronkema 
Wayne State University 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wayne.edu/som_srs 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Sood MD, Akshay; Corsi, Nicholas; Butaney MD, Mohit; Keeley MS, Jacob; Bronkema, Chandler; Affas MD, 
Ziad; Farah, Guillaume; Chien, Michael; Hanna, Renee; Wertheimer, Stephen; Chang MD, Steven; Rambhatla 
MD, Amarnath; Stricker MD, Hans; Peabody MD, James; Menon MD, Mani; Rogers MD, Craig; Rakic, Nikola; 
and Abdollah MD, Firas, "30-Day Mortality and Cardiopulmonary Complication Rates in Patients 
Undergoing Emergency Surgery with Perioperative SARS-CoV-2 Infection" (2021). Medical Student 
Research Symposium. 91. 
https://digitalcommons.wayne.edu/som_srs/91 
This Research Abstract is brought to you for free and open access by the School of Medicine at 
DigitalCommons@WayneState. It has been accepted for inclusion in Medical Student Research Symposium by an 
authorized administrator of DigitalCommons@WayneState. 
Authors 
Akshay Sood MD, Nicholas Corsi, Mohit Butaney MD, Jacob Keeley MS, Chandler Bronkema, Ziad Affas 
MD, Guillaume Farah, Michael Chien, Renee Hanna, Stephen Wertheimer, Steven Chang MD, Amarnath 
Rambhatla MD, Hans Stricker MD, James Peabody MD, Mani Menon MD, Craig Rogers MD, Nikola Rakic, 
and Firas Abdollah MD 
This research abstract is available at DigitalCommons@WayneState: https://digitalcommons.wayne.edu/som_srs/91 
INTRODUCTION
METHODS
• In March 2020, all hospitals in the state of Michigan were ordered to 
suspend non-essential surgical procedures1
• There are limited data2,3 regarding the combined impact of COVID-19 
surgical intervention on patient outcomes in whom surgery cannot be 
postponed 
• This study sought to answer the question: are patients undergoing an 
emergency surgical intervention who have SARS-CoV-2 infection or 
acquire it during the post-operative period at increased risk for 
mortality compared to COVID-19 positive counterparts? 
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RESULTS
REFERENCES
•There were no differences in 30-day mortality rate or in the rate of cardiac and 
pulmonary complications among patients undergoing emergency surgery versus 
not – a significant proportion of patients were of Black race (surgical arm: 38.5% 
vs. control 54.1%, p=0.072) and female gender in either of the study groups. 
•The 30-day mortality rate was 17.3% in COVID-19 positive patients who had 
surgery compared to 13.1% in those who did not (p=0.408)  (Table 1) 
•Patient age and made gender were associated with an increased odds for 30-
day mortality (OR 1.07, p<0.001 and OR 2.57, p=0.007) and cardiac (OR 1.05, 
p=0.001 and OR 2.53, p=0.002)
•Charleston Comorbidity Index and race did not have an impact on 30-day 
mortality or cardiopulmonary complications in COVID-19 positive patients (Table 
2)
•Our findings strengthen the existing literature, these results are in-
line with the COVIDSurg Collaborative Study – a large observational 
study of perioperative SARS-CoV-2 infection that reported 30-day 
mortality rate of 23.8%4
•Similarity, another study that reported on 34 patients in Wuhan, 
China, at the origin of the pandemic, noted a mortality rate of 20.5% 
who were unintentionally scheduled for elective surgery5
•However, both of these studies were limited by lack of a control 
group
•Our study identifies the same risk factors for increased mortality 
and cardiopulmonary that have been recognized2,3
•However, our study has several limitations, as it is a retrospective 
cohort at a single tertiary-care center in an inner-city 
neighborhood that had a significant number of COVID-19 cases, 
thus limiting generalizability 
•We tried to minimize confounding bias and increase the 
applicability to a more general SARS-CoV-2 infected population 
by using a multivariable adjusted analyses
•Second, the follow-up period is limited to 30-days
•The importance of this study is that an emergency intervention 
does not portend a poorer prognosis among patients with a 
confirmed SARS-CoV-2 infection 
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CONCLUSION
Data Source, Study Population, Study Period
Retrospective review of adult patients diagnosed at Henry Ford Hospital 
between March and May 2020. COVID-19 patients stratified into two 
groups: emergency surgery (n=133) vs. not (n=7,948).  Control and 
intervention arms were constructed (Figure 1).  Controls matched to patients 
utilizing a 1:6 propensity score matching, based on age, race, body mass 
index, and postal code (proxy for socioeconomic status) 
Covariates
Clinical parameters were noted: age at diagnosis, race, gender, BMI, 
comorbidities, history of organ transplant, and diagnosis of active cancer. 
Additionally, details on whether the COVID-19 diagnosis was clinical or a 
laboratory test (>95% patients had lab test proven SARS-CoV-2 infection)
Endpoints
The primary outcome of interest in our study was 30-day mortality. 
Secondary outcomes: cardiac and pulmonary complications 
Given limited sample size, composite endpoints for complications were 
developed. These included hypoxic respiratory failure, acute respiratory 
distress syndrome, and new-onset arrythmia, among others
Statistical Analysis 
Descriptive statistics of categorical variables focused on frequencies and 
proportions. Chi-Square and Mann-Whitney U tests were used to compare 
proportions. Covariates were tested for interactions. Multivariable logistic 
regression analyses were used to test the association between covariates 
and odds of mortality. 
Figure 1: Study flowchart of patients diagnosed with SARS-CoV-2 
infection that underwent emergent surgical intervention (n=52) versus not 
(n=314) at a single tertiary-care institute, March-May 2020. 
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Key Point: Based on our single center retrospective study, we 
demonstrate that patients undergoing emergency surgery with a 
co-diagnosis of COVID-19 in the perioperative period do not have 
an increased risk for short term mortality compared to medically 
treated COVID-19 patients. 
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